2004 Case #3 | ||
Diagnosis: Subclinical neurosyphilis with pan-uveitis. |
Discussion: Serum VDRL 1:64. FTA-Abs positive. CSF VDRL 1:2. Serum and CSF cryptococcal antigen negative. Brucella and salmonella agglutination negative. CSF gram stain and acid-fast negative. HIV ELISA positive with CD4 count of 145.
The differential diagnosis of infectious uveitis in a tropical environment such as ours includes most commonly tuberculosis and brucellosis, with bartonellosis and histoplasmosis being less common. This is the 3rd such case of uveitis due to syphilis in the setting of HIV we have seen in the past 12 months. In the pre-AIDS era, ocular syphilis was described as presenting either as a panuveitis as a manifestation of secondary syphilis (syphilitic meningitis), or as a manifestation of tertiary syphilis with optic neuritis, retinal degeneration, or Argyll-Robertson pupil. These latter changes were irreversible in the pre-antibiotic era. Uveitis is defined as acute (symptoms <3 months) or chronic (symptoms >3 months or insidious/indeterminant). With the appearance of AIDS, syphilis has begun to appear with clear-cut neurologic involvement earlier in its course (Clin Infect Dis 2001;32:1661-73). It is increasingly clear that syphilis patients who present initially with an isolated chronic posterior or pan-uveitis, especially in the setting of HIV (which is present in more than half these individuals), have this as a manifestation of what is demonstrably neurosyphilis. Our patient had predominantly posterior uveitis but the mild iritis means that this is a pan-uveitis. Those with acute uveitis (<3 months) generally have early or secondary syphilis but most of those with HIV co-infection have concomitant neurosyphilis. Important questions still remain about the current disease spectrum of ocular syphilis and its relationship with neurosyphilis. Nevertheless, because of the frequent association of syphilitic posterior uveitis or pan-uveitis with sub-clinical neurosyphilis, current CDC and international guidelines indicate that all such patients, irrespective of ocular disease intensity should be given a full course of treatment for neurosyphilis. In addition to direct effect on the eye disease, the other goal of therapy would be to prevent the development of symptomatic neurosyphilis. Our patient was treated intravenously for 2 weeks with 18 million IU of Penicillin G per day as well as with Prednisone 50 mg/day. At the end of treatment visual acuity in the L eye improved to 20/50 and in the R eye to 20/25. The paleness of the optic disk temporally persisted and this optic atrophy is a typical sequelae of syphilitic neuritis.
|